Efficacy of risankizumab in patients with moderate-to-severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: an integrated analysis of the phase III UltIMMa-1 and UltIMMa-2 studies. (Record no. 30886495)

MARC details
000 -LEADER
fixed length control field 01522 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518100218.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202105s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1468-3083
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1111/jdv.16521
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Strober, B
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20210514
245 00 - TITLE STATEMENT
Title Efficacy of risankizumab in patients with moderate-to-severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: an integrated analysis of the phase III UltIMMa-1 and UltIMMa-2 studies.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of the European Academy of Dermatology and Venereology : JEADV
Date of publication, distribution, etc. Dec 2020
300 ## - PHYSICAL DESCRIPTION
Extent 2830-2838 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biological Therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Demography
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Psoriasis
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Severity of Illness Index
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ustekinumab
General subdivision therapeutic use
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Menter, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Leonardi, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gordon, K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lambert, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Puig, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Photowala, H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Longcore, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zhan, T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Foley, P
773 0# - HOST ITEM ENTRY
Title Journal of the European Academy of Dermatology and Venereology : JEADV
Related parts vol. 34
-- no. 12
-- p. 2830-2838
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1111/jdv.16521">https://doi.org/10.1111/jdv.16521</a>
Public note Available from publisher's website

No items available.